Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac Surgery: The VANCS Randomized Controlled Trial.

LA, Hajjar; JL, Vincent; Gomes Galas FR, Barbosa; A, Rhodes; G, Landoni; EA, Osawa; RR, Melo; MR, Sundin; SM, Grande; FA, Gaiotto; PM, Pomerantzeff; LO, Dallan; RA, Franco; RE, Nakamura; LA, Lisboa; Almeida JP, de; AM, Gerent; DH, Souza; MA, Gaiane; JT, Fukushima; CL, Park; C, Zambolim; Ferreira GS, Rocha; TM, Strabelli; FL, Fernandes; L, Camara; S, Zeferino; VG, Santos; MA, Piccioni; FB, Jatene; Auler JO Jr, Costa; RK, Filho

doi:10.1097/aln.0000000000001434

Public

Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac Surgery: The VANCS Randomized Controlled Trial.

Shared by NobleBlocks on Jan 1, 2017 • 12:00 AM UTC

Authors:

Hajjar LA

Vincent JL

Barbosa Gomes Galas FR

Abstract

Background Vasoplegic syndrome is a common complication after cardiac surgery and impacts negatively on patient outcomes. The objective of this study was to evaluate whether vasopressin is superior to norepinephrine in reducing postoperative complications in patients with vasoplegic syndrome.Methods...

Discussions